Icosavax Reports Positive Results From Phase 1 Trial Of IVX-A12 Against RSV & HMPV In Older Adults
23/5 05:25
(RTTNews) - Icosavax Inc. (ICVX) announced positive interim results from its Phase 1 clinical trial of IVX-A12 against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults....